Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Schoen Eric, holds the title of Chief Financial Officer at FILANA THERAPEUTICS, INC..
On 2026-11-16, the insider transacted 20,000 shares.The shares were transacted at a weighted average price of $0.42 per share, resulting in a total market-relevant value of $8K.
Schoen Eric (Chief Financial Officer) bought $8K of $FLNA
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.